Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15Parkinson Disease 4, Autosomal Dominant Lewy Body 3Stomach Neoplasms 2Neoplasm Metastasis 2Carcinoma 2Spinocerebellar Degenerations 1Rectal Neoplasms 1Neoplasms 1HER2 IHC3+ Advanced Colorectal Cancer 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Diseases 1Advanced Colorectal Cancer 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Fluorouracil 3Bevacizumab 3Oxaliplatin 2Leucovorin 2Irinotecan 2trifluridine tipiracil drug combination 1sintilimab 1napabucasin 1encorafenib 1S-1 plus cisplatin 1Paclitaxel 1Oviposition 1Levoleucovorin 1Infliximab 1Drug Therapy 1Drainage 1Cisplatin 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Gastrointestinal Diseases × trifluridine tipiracil drug combination × Clear all
NCT04457297 2026-01-21

ALTAIR

National Cancer Center Hospital East

Phase 3 Completed
243 enrolled 13 charts
Gastrointestinal

Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡